NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0101
-0.0499 (-83.17%)
Jul 30, 2026, 3:42 PM EST
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $1.32 million as of July 31, 2026. Its market cap has decreased by -87.40% in one year.
Market Cap
1.32M
Enterprise Value
39.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 1.32M, a decrease of -99.61%. That is a compound annual growth rate of -84.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.32M | -78.79% |
| Dec 31, 2025 | 6.22M | -73.65% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Path Holdings | 1.91M |
| Sirona Biochem | 1.35M |
| Hepion Pharmaceuticals | 1.34M |
| Avenue Therapeutics | 1.28M |
| Neon Bloom | 1.27M |
| Abpro Holdings | 1.24M |
| Innovation Pharmaceuticals | 1.06M |
| AXIM Biotechnologies | 1.05M |